Blood-Pressure-Lowering Peptides Discovered in Traditional Himalayan Fermented Cheese

Researchers fermented chhurpi cheese using native Lactobacillus delbrueckii WS4 bacteria and analyzed the peptide content across different stages of simulated gastrointestinal digestion. They used computational tools to predict ACE inhibitory potential, then synthesized the most promising peptides and validated their activity in vitro. Testing included ACE inhibition assays, HOCl reduction, MPO inhibition, and molecular docking simulations to understand binding mechanisms.

Food-derived peptides that lower blood pressure naturally are a growing area of research, with some (like lactotripeptides from milk) already in commercial supplements. This study expands the search to an underexplored source — traditional Himalayan fermented cheese — and identifies peptides with dual blood-pressure-lowering and antioxidant properties. The fact that these peptides survive digestion makes them potentially viable as functional food ingredients.

The hunt for natural ACE-inhibitory peptides in food is a well-established research field, with dairy products being a particularly rich source. This study extends the search to a little-known traditional cheese, demonstrating that indigenous fermented foods from remote regions may contain unique bioactive peptides not found in commercial dairy. As interest grows in functional foods and natural alternatives to pharmaceuticals, characterizing the peptide content of traditional fermented foods opens new doors for nutraceutical development.

This is entirely in vitro and in silico work — no animal or human studies were conducted. Lab-based ACE inhibition doesn't guarantee blood pressure reduction in living systems. The peptide concentrations achievable through eating cheese may be far below therapeutic levels. Bioavailability in humans (absorption, distribution, metabolism) remains unknown.